Study of TDM-180935 in Atopic Dermatitis Patients

Conditions: Atopic Dermatitis Interventions: Drug: TDM-180935 topical ointment 1.0%; Drug: TDM-180935 topical ointment 2.0%; Drug: TDM-180935 topical vehicle ointment 1; Drug: TDM-180935 topical vehicle ointment 2 Sponsors: Technoderma Medicines Inc.; Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials